An observational pilot study of a novel loss of resistance syringe for locating the epidural space
Copyright © 2021 Elsevier Ltd. All rights reserved..
BACKGROUND: The EpiFaith® syringe is a novel loss-of-resistance syringe that utilizes a spring-loaded plunger that automatically moves forward within the syringe when there is a loss of resistance. We evaluated the syringe in a clinical setting among a cohort of pregnant women receiving neuraxial labor analgesia.
METHODS: In a non-randomized observational study, four anesthesiologists used the EpiFaith® syringe 10 times each while placing epidural catheters for labor analgesia. The anesthesiologists scored each placement on an 11-point Likert scale (-5 = absolutely worse, 0 = the same, and 5 = absolutely better than using their regular loss-of-resistance syringe technique).
RESULTS: All 40 neuraxial placements correctly located the epidural space. Air was used in the syringe in 35 of the 40 cases. In 50%, 27.5% and 22.5% of cases the anesthesiologists reported that using the EpiFaith® syringe was better than, the same as, or worse than using their regular syringe, respectively. There were no inadvertent dural punctures.
CONCLUSIONS: This feasibility study found that three of the four anesthesiologists scored the EpiFaith® syringe as better or the same as using their regular loss-of-resistance syringe. More extensive studies are required to determine if the EpiFaith® syringe reduces adverse outcomes such as unintentional dural punctures.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:47 |
|---|---|
| Enthalten in: |
International journal of obstetric anesthesia - 47(2021) vom: 07. Aug., Seite 102984 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Athar, M W [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Anesthesia, epidural |
|---|
| Anmerkungen: |
Date Completed 10.12.2021 Date Revised 14.12.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.ijoa.2021.102984 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM325455627 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM325455627 | ||
| 003 | DE-627 | ||
| 005 | 20231225192456.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ijoa.2021.102984 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1084.xml |
| 035 | |a (DE-627)NLM325455627 | ||
| 035 | |a (NLM)33994273 | ||
| 035 | |a (PII)S0959-289X(21)00042-X | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Athar, M W |e verfasserin |4 aut | |
| 245 | 1 | 3 | |a An observational pilot study of a novel loss of resistance syringe for locating the epidural space |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 10.12.2021 | ||
| 500 | |a Date Revised 14.12.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2021 Elsevier Ltd. All rights reserved. | ||
| 520 | |a BACKGROUND: The EpiFaith® syringe is a novel loss-of-resistance syringe that utilizes a spring-loaded plunger that automatically moves forward within the syringe when there is a loss of resistance. We evaluated the syringe in a clinical setting among a cohort of pregnant women receiving neuraxial labor analgesia | ||
| 520 | |a METHODS: In a non-randomized observational study, four anesthesiologists used the EpiFaith® syringe 10 times each while placing epidural catheters for labor analgesia. The anesthesiologists scored each placement on an 11-point Likert scale (-5 = absolutely worse, 0 = the same, and 5 = absolutely better than using their regular loss-of-resistance syringe technique) | ||
| 520 | |a RESULTS: All 40 neuraxial placements correctly located the epidural space. Air was used in the syringe in 35 of the 40 cases. In 50%, 27.5% and 22.5% of cases the anesthesiologists reported that using the EpiFaith® syringe was better than, the same as, or worse than using their regular syringe, respectively. There were no inadvertent dural punctures | ||
| 520 | |a CONCLUSIONS: This feasibility study found that three of the four anesthesiologists scored the EpiFaith® syringe as better or the same as using their regular loss-of-resistance syringe. More extensive studies are required to determine if the EpiFaith® syringe reduces adverse outcomes such as unintentional dural punctures | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Observational Study | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Anesthesia, epidural | |
| 650 | 4 | |a Anesthesia, obstetrical | |
| 650 | 4 | |a Syringes | |
| 700 | 1 | |a Guo, N |e verfasserin |4 aut | |
| 700 | 1 | |a Ortner, C |e verfasserin |4 aut | |
| 700 | 1 | |a Carvalho, B |e verfasserin |4 aut | |
| 700 | 1 | |a Abir, G |e verfasserin |4 aut | |
| 700 | 1 | |a Riley, E T |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t International journal of obstetric anesthesia |d 1991 |g 47(2021) vom: 07. Aug., Seite 102984 |w (DE-627)NLM091552982 |x 1532-3374 |7 nnns |
| 773 | 1 | 8 | |g volume:47 |g year:2021 |g day:07 |g month:08 |g pages:102984 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ijoa.2021.102984 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 47 |j 2021 |b 07 |c 08 |h 102984 | ||